Editor - Arsenio M Fialho | Instituto Superior Tecnico | 4592
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google Scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Arsenio M Fialho

Arsenio M Fialho
Arsenio M Fialho
Institute for Biotechnology and BioEngineering (IBB)
Instituto Superior Tecnico


Arsenio M Fialho is an Associate Professor with habilitation at the Bioengineering Department, Instituto Superior Tecnico IST, Technical University of Lisbon, Portugal, and a Researcher member of the Centre for Biological and Chemical Engineering, Institute of Bioengineering and Biotechnology.

Research Interest

Research interests are dealing with the biosynthesis and role of bacterial exopolysaccharides, particularly, the commercial gellan gum from Sphingomonas elodea and the exopolysaccharide produced by Burkholderia cepacia isolates from cystic fibrosis patients. His current scientific interests are also centred on the study of bacterial proteins, such as cupredoxins, as novel drug candidates with anti-cancer activity.  Complementarily, he has been deeply interested in Bioinformatic and comparative analysis of Burkholderia genomes.



Global Speakers in the subject

Global Experts in the subject